What factors fuel the global infusion pump market?

Key drivers include chronic conditions and an ageing population.

An increasing prevalence of chronic diseases is expected to drive the global infusion pump market to rise by $4.99b through 2028 at a compound annual growth rate of 6.78%, said Technavio.

Driven by a rise in conditions such as diabetes and cancer, infusion pumps are increasingly relied upon in hospitals, healthcare centres, speciality clinics, and even homes for long-term patient care.

“Home infusion therapy and portable infusion pumps have reduced hospital stays, making treatment more accessible and convenient for patients,” the report said.

Moreover, the growing demand is also linked to an ageing population and the rise in conditions like hypertension and neurological disorders.

Meanwhile, the market is witnessing a trend towards advanced infusion pumps, which include features such as barcode scanning, sensors, and EHR integration.

These pumps can be programmed to administer medications with precise infusion rates, dose limits, and schedules, and calculate dosages based on factors like weight and body surface area.